It causes the heart chamber to narrow at the top and widen at the bottom, losing pumping strength in the process ...

It causes the heart chamber to narrow at the top and widen at the bottom, losing pumping strength in the process ...

The syndrome often follows severe emotional upheaval, such as bereavement, illness, or trauma, earning it the moniker 'broken ...

Mount Sinai researchers studying a type of heart disease known as hypertrophic cardiomyopathy (HCM) have calibrated an artificial intelligence (AI) algorithm to quickly and more specifically identify ...

Cobenfy’s late-stage flop is BMS’ second high-profile failure in as many weeks. The pharma announced last week that Camzyos ...

A Willerby man is running the London Marathon to raise awareness for a heart condition his younger brother was diagnosed with ...

Mount Sinai researchers studying a type of heart disease known as hypertrophic cardiomyopathy (HCM) have calibrated an artificial intelligence (AI) algorithm to quickly and more specifically identify ...

Mount Sinai researchers studying a type of heart disease known as hypertrophic cardiomyopathy (HCM) have calibrated an ...

FDA approves Camzyos label update easing echo monitoring and lifting drug interaction limits, supported by 3.5 years of safety data and real-world use ...

Black women are potentially three times more likely to get peripartum cardiomyopathy — a kind of heart failure.

Bristol Myers Squibb's drug to treat a type of heart disease did not significantly improve functional capacity and symptoms ...

According to analysts at BMO Capital Markets, non-obstructive hypertrophic cardiomyopathy would have meant a $1.3 billion ...